INS and Hypoglycemia: Insulin-LMWP conjugates mucoadhesive nanoparticles showed an oral insulin bioavailability of 17.98 ± 5.61%, as well as enhanced hypoglycemia effect by two-fold higher than the nanoparticles loaded-mere insulin [110].